These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30422329)

  • 1. Review: Fluid biomarkers for frontotemporal dementias.
    Zetterberg H; van Swieten JC; Boxer AL; Rohrer JD
    Neuropathol Appl Neurobiol; 2019 Feb; 45(1):81-87. PubMed ID: 30422329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontotemporal Dementias.
    Finger EC
    Continuum (Minneap Minn); 2016 Apr; 22(2 Dementia):464-89. PubMed ID: 27042904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological phenotypes of frontotemporal dementia: Perspectives for disease modifying therapies.
    Gazzina S; Manes MA; Padovani A; Borroni B
    Eur J Pharmacol; 2017 Dec; 817():76-85. PubMed ID: 28579383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural brain imaging in frontotemporal dementia.
    Rohrer JD
    Biochim Biophys Acta; 2012 Mar; 1822(3):325-32. PubMed ID: 21839829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural variant frontotemporal dementia--defining genetic and pathological subtypes.
    Rohrer JD
    J Mol Neurosci; 2011 Nov; 45(3):583-8. PubMed ID: 21559874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical parkinsonian syndromes: a general neurologist's perspective.
    Deutschländer AB; Ross OA; Dickson DW; Wszolek ZK
    Eur J Neurol; 2018 Jan; 25(1):41-58. PubMed ID: 28803444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontotemporal dementia with cortico-basal syndrome].
    Zalyalova ZA; Munasipova SE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(2):107-114. PubMed ID: 35271245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy and clinical trials in frontotemporal dementia: past, present, and future.
    Tsai RM; Boxer AL
    J Neurochem; 2016 Aug; 138 Suppl 1(Suppl 1):211-21. PubMed ID: 27306957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
    Stamelou M; Diehl-Schmid J; Hapfelmeier A; Kontaxopoulou D; Stefanis L; Oertel WH; Bhatia KP; Papageorgiou SG; Höglinger GU
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1264-8. PubMed ID: 26324212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontotemporal dementias].
    Witt K; Deuschl G; Bartsch T
    Nervenarzt; 2013 Jan; 84(1):20-32. PubMed ID: 22366755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging and fluid biomarkers in frontotemporal dementia.
    Meeter LH; Kaat LD; Rohrer JD; van Swieten JC
    Nat Rev Neurol; 2017 Jul; 13(7):406-419. PubMed ID: 28621768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.
    Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL
    Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: Clinical, genetic and neuroimaging features of frontotemporal dementia.
    Convery R; Mead S; Rohrer JD
    Neuropathol Appl Neurobiol; 2019 Feb; 45(1):6-18. PubMed ID: 30582889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining Neuropsychiatric Inventory scale differences across frontotemporal dementia syndromes.
    Yiannopoulou KG; Papatriantafyllou JD; Ghika A; Tsinia N; Lykou E; Hatziantoniou E; Agiomyrgiannakis D; Kyrozis A; Papageorgiou SG
    Psychogeriatrics; 2019 Jan; 19(1):32-37. PubMed ID: 30073726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.
    Snowden JS; Thompson JC; Stopford CL; Richardson AM; Gerhard A; Neary D; Mann DM
    Brain; 2011 Sep; 134(Pt 9):2478-92. PubMed ID: 21840888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into biological markers of frontotemporal lobar degeneration spectrum.
    Borroni B; Alberici A; Archetti S; Magnani E; Di Luca M; Padovani A
    Curr Med Chem; 2010; 17(10):1002-9. PubMed ID: 20156164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontotemporal dementia: Review of 63 cases].
    Donoso S A; Figueroa V C; Gómez R R; Behrens P MI
    Rev Med Chil; 2009 Jul; 137(7):900-5. PubMed ID: 19802417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau-mediated dysregulation of RNA: Evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies.
    Koren SA; Galvis-Escobar S; Abisambra JF
    Neurobiol Dis; 2020 Jul; 141():104939. PubMed ID: 32413399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.